Nature:抗癌“神药”也救不了肿瘤耐药?原来癌细胞偷偷改了代谢方式,抑制脂肪酸代谢是突破口

2021-08-19 生物探索 生物探索

癌细胞耐药怎么破?

在很多时候,癌细胞就像是“打不死的小强”,即使在实验室中展现出惊人疗效的治疗药物,也难以阻挡一部分癌细胞“死里逃生”的脚步,更可气的是,这些残存的癌细胞能够继续增殖,无视杀伤性药物并持续“壮大”队伍,导致疾病再次复发和耐药性问题的恶化,最终令患者面临死亡的威胁。 为了揭开部分癌细胞能够抵抗药物治疗的原因,哈佛医学院、麻省理工学院以及博德研究所的研究人员合作开发了一种独特的DNA追踪系统,对药物作用下癌细胞的变化进行了追踪,最终找到部分癌细胞“强悍”到无惧药物攻击的原因。 原来,在疾病治疗早期,一部分癌细胞便展现出“刀枪不入”的特质,其中少部分癌细胞甚至能够随着药物反应而改变自己的代谢方式,从而保持生长和繁殖的能力,如果阻断这些癌细胞独特的代谢途径,便能够抑制耐药细胞进一步扩张,增强癌症治疗效果。相关报告以Cycling cancer persister cells arise from lineages with distinct programs为题发表在8月11日的《Nature》期刊上。 https://doi.org/10.1038/s41586-021-03796-6 在这项

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1064857, encodeId=26f7106485e3f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLWROGia7f3ficvom5MMQRnYVzLg9ibA7gJvvUeGDuylYP3de77n3NvQucKFsdz5F2npWEA3arQwxrKQ/132, createdBy=09ed2341770, createdName=心之方向, createdTime=Thu Oct 28 23:56:06 CST 2021, time=2021-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1885368, encodeId=73fb188536816, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon Sep 27 19:49:38 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252786, encodeId=96611252e8632, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Sat Aug 21 08:49:38 CST 2021, time=2021-08-21, status=1, ipAttribution=)]
    2021-10-28 心之方向

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1064857, encodeId=26f7106485e3f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLWROGia7f3ficvom5MMQRnYVzLg9ibA7gJvvUeGDuylYP3de77n3NvQucKFsdz5F2npWEA3arQwxrKQ/132, createdBy=09ed2341770, createdName=心之方向, createdTime=Thu Oct 28 23:56:06 CST 2021, time=2021-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1885368, encodeId=73fb188536816, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon Sep 27 19:49:38 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252786, encodeId=96611252e8632, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Sat Aug 21 08:49:38 CST 2021, time=2021-08-21, status=1, ipAttribution=)]
    2021-09-27 liye789132251
  3. [GetPortalCommentsPageByObjectIdResponse(id=1064857, encodeId=26f7106485e3f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLWROGia7f3ficvom5MMQRnYVzLg9ibA7gJvvUeGDuylYP3de77n3NvQucKFsdz5F2npWEA3arQwxrKQ/132, createdBy=09ed2341770, createdName=心之方向, createdTime=Thu Oct 28 23:56:06 CST 2021, time=2021-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1885368, encodeId=73fb188536816, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon Sep 27 19:49:38 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252786, encodeId=96611252e8632, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Sat Aug 21 08:49:38 CST 2021, time=2021-08-21, status=1, ipAttribution=)]
    2021-08-21 yxch36

相关资讯

Cell:肿瘤治疗新方向——药物干预RNA剪接可增强肿瘤免疫

药物干预RNA剪接对抗肿瘤免疫的增强作用。

今晚19:30直播:CSCO BC聂建云教授:年轻乳腺癌的治疗要点和生育管理

前100位报名者可免费申领《肿瘤内科诊疗策略》1本

Nat Commun:锁定“不可成药靶点”,攻克臭名昭著的癌基因

一种靶向“RAS”突变蛋白的新方法,他们在RAS表面发现了一个“裂缝”,可以用来开发新型抗癌药物。

oncogene:“令人窒息”的癌症,为什么缺氧微环境反而让肿瘤变得穷凶极恶?

研究基于一种基因编辑技术,向我们展示了靶向 HIF-1α是如何抑制肿瘤生长,并将细胞毒性T淋巴细胞(CTL)驱动到肿瘤组织内的。

Science Translational Medicine:低剂量放射性核素靶向治疗,让冷肿瘤变热,提高免疫疗法响应

2021年7月14日,来自匹兹堡大学医学院和威斯康星大学麦迪逊分校的研究团队在 Science Translational Medicine 期刊发表了题为:Low-dose targeted rad